Registry following pain treatments for people with knee osteoarthritis
Collects information on pain care for people with knee osteoarthritis.
Key facts
- Who runs it
- Pacira Pharmaceuticals, Inc
- Where
- Alexandria, Asheville, Baltimore, Bethesda, DeLand, DuBois, Garden City, Germantown, Irvine, Jersey City, Los Angeles, New Hartford, New Orleans, North Chelmsford, Omaha, Phoenix, Salt Lake City, State College, and Tulsa, United StatesSee the 19 sites
- Trial code
- Registry title
- Innovations in Genicular Outcomes Registry
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 23 Sept 2021
- Expected to end
- 30 Dec 2033
- Type of study
- Observational
- Treatments tested
- Treatment for Knee OA
- Record updated
- 23 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with knee osteoarthritis (OA) pain who plan to get treatment for it. This can be knee injections, nerve blocking procedures or knee replacement surgery within 60 days.
- Sex
- All sexes can join.
- Disease stage
- Knee pain from osteoarthritis (wear of the knee joint) that needs treatment on the target knee.
Main reasons for not taking part
- People in another research trial that would stop them from getting the site's standard care for knee OA pain or knee replacement recovery cannot join.
- People planning surgery other than on the target knee cannot join.
- People who cannot understand the consent form and questionnaires, or cannot fill them in, cannot join.
- People without a smartphone, or internet access with a computer or tablet, cannot join.
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening
- Able to understand the informed consent and assessment questionnaires and have the ability to complete them in the opinion of the investigator
- Have access to a smartphone or internet access with a computer/tablet to complete the questionnaires using the registry application
Who cannot take part
- Actively enrolled in an investigational trial that would preclude patients from receiving the site's standard of care for knee OA pain or knee arthroplasty recovery protocol
- Planning to have a surgery other than on the target knee
Where in United States
- MidState Orthopedics and Sports MedicineAlexandria, United StatesContact: David Rogenmoser, DO (principal investigator)Taking people
- Blue Nine SystemsAsheville, United StatesContact: Kate Fasel, BSNNo longer taking part
- Sinai Hospital of BaltimoreBaltimore, United StatesContact: Michael Mont, MD (principal investigator)Taking people
- Henry M Jackson Foundation for the Advancement of Military Medicine/Walter Reed National Military Medical CenterBethesda, United StatesContact: Kate Fasel, BSNNo longer taking part
- Florida Orthopaedic AssociatesDeLand, United StatesContact: Mark Hollmann, MD (principal investigator)Taking people
- Penn Highlands DuBoisDuBois, United StatesContact: Christopher Varacallo, DO (principal investigator)Taking people
- Northwell HealthGarden City, United StatesContact: Giles Scuderi, MD (principal investigator)Taking people
- Campbell ClinicGermantown, United StatesContact: William Mihalko, MD (principal investigator)Taking people
- Orthopedic Education and Research Institute of So Ca (Hoag)Irvine, United StatesContact: Adam Rivadeneyra, MD (principal investigator)Taking people
- Jersey City Medical CenterJersey City, United StatesContact: Kate Fasel, BSNNo longer taking part
- Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Andrew Spitzer, MD (principal investigator)Taking people
- Genesee Orthopedics and Plastic Surgery (St. Elizabeth Med Center/ Apex Surgical Center)New Hartford, United StatesContact: Kate Fasel, BSNNo longer taking part
- Louisiana State University /OchsnerNew Orleans, United StatesContact: Vinod Dasa, MD (principal investigator)Taking people
- Orthopaedic Surgical AssociatesNorth Chelmsford, United StatesContact: Scott Sigman, MD (principal investigator)Taking people
- OrthoNebraska ClinicsOmaha, United StatesContact: Joshua Urban, MD (principal investigator)Taking people
- The MORE FoundationPhoenix, United StatesContact: Anuj Daftari, MD (principal investigator)Taking people
- University of UtahSalt Lake City, United StatesContact: Alexandra Fogarty, MD (principal investigator)Taking people
- University Orthopedics CenterState College, United StatesContact: Thomas Ellis, DO (principal investigator)Taking people
- Oklahoma Surgical HospitalTulsa, United StatesContact: Sarat Kunapuli, DO (principal investigator)Taking people
About the trial
What the trial wants to find out
The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs [NSAIDs]).
The group in the trial
- All participants
Eligible and enrolled subjects with knee OA pain who require treatment on the target knee as a part of pain management.
Treatment: Treatment for Knee OA
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Innovations in Genicular Outcomes Registry
- Plain-language title
- Registry following pain treatments for people with knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Innovations in Genicular Outcomes Registry (IGOR): protocol for a real-world registry study of treatments for knee osteoarthritis.Therapeutic advances in musculoskeletal disease, 2024
- Record updated
- 23 July 2026